Haystack Oncology Building Out Clinical Lab at Baltimore Peninsula
By Keith Loria November 17, 2022 5:29 pm
reprints
Biotech firm Haystack Oncology has signed a 20,000-square-foot lease within the City Garage Science & Technology Center in South Baltimore, Commercial Observer has learned.
Located at 101 West Dickman Street, the 135,000-square-foot life sciences building is owned by South Duvall, which acquired the property in October 2021.
The building is part of mixed-use community Baltimore Peninsula, which, upon completion, will include more than 14 million square feet of office, retail and residential space. The development team includes MAG Partners, MacFarlane Partners, Sagamore Ventures and the Urban Investment Group within Goldman Sachs.
Haystack Oncology, which focuses on precision medicine, will move from its current facility at 301 West 29th Street in the Remington section of Baltimore next spring.
The new space will feature an open office design with clinical diagnostic, research and sample processing labs. Additionally, the space will use mechanical and electrical systems to support energy and HVAC requirements, according to the company.
“We’re looking forward to building out a state-of-the-art clinical laboratory at City Garage to support the innovations in precision medicine that Haystack Oncology is delivering to the clinic,” Dan Edelstein, Haystack Oncology’s CEO and president, said in a prepared statement. “Accessibility to the extraordinary life science expertise in the Baltimore region makes the location particularly attractive.”
Mark Deering, a partner with MacKenzie Commercial Real Estate Services, represented the tenant in the deal, while Nate Crowe of Scheer Partners represented the landlord.
Update: This story originally misattributed source material. This has been corrected. We apologize for the error.
Keith Loria can be reached at Kloria@commercialobserver.com.
